The judge in the case of Teladoc versus the Texas Medical Board has denied the board’s motion to dismiss the suit, responding to each of three claims that the suit was invalid, originally made in September. In the process, Judge Robert Pitman settled the issue of “active supervision”, a highly salient point in the case.
In April, Teladoc sued the Texas Medical Board, alleging that a 2010 rule requiring doctors to have an in-person or face-to-face visit with a patient in order to prescribe medication, is in violation of antitrust laws and serves to restrict competition from telemedicine companies.
The Board petitioned to have the case thrown out for three different reasons: that the four-year statute of limitations for antitrust cases had expired since the passing of the 2010 rule; that the state actor immunity they were claiming was an immunity to suit; and that certain claims Teladoc made with regards to the Commerce Clause, which asserted that the board’s rules illegally limited interstate commerce, were unfounded.
Full content: BusinessWire
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI